Literature DB >> 14568187

Steroid hormone regulation of the human kallikrein 10 (KLK10) gene in cancer cell lines and functional characterization of the KLK10 gene promoter.

Liu-Ying Luo1, Linda Grass, Eleftherios P Diamandis.   

Abstract

BACKGROUND: The human kallikrein 10 (KLK10) gene is a new member of the human tissue kallikrein gene family. It encodes for a secreted serine protease (hK10) with predicted trypsin-like enzymatic activity. KLK10 is highly expressed in the sex organs and its expression level changes in malignancy.
METHODS: To determine the role of steroid hormones in KLK10 gene expression, we investigated its modulation by 17beta-estradiol, 5alpha-dihydrotestosterone, norgestrel, dexamethasone and aldosterone, at both the transcription and translation level, in a panel of cancer cell lines. After steroid hormone stimulation, the change of KLK10 mRNA was monitored with reverse transcriptase polymerase chain reaction and hK10 protein levels in the culture supernatant were quantified with an hK10-specific immunoassay. The presence of hormone response elements in the KLK10 gene promoter was examined with the chloramphenicol acetyltransferase reporter gene system.
RESULTS: The KLK10 expression was mainly up-regulated by estrogens, androgens and progestins, and to a lesser extent by dexamethasone and aldosterone in the breast cancer cell lines BT-474, MCF-7 and T-47D, both at the mRNA and protein levels. The effect of stimulation of these steroids on KLK10 expression varied among the cell lines. Estrogens, androgens and progestins were most potent in the BT-474, T-47D and MCF-7 cells, respectively. The up-regulation effect of estrogens, androgens, and progestins on KLK10 expression can be blocked by their antagonists ICI-182, 780, RU-56,187, and mifepristone, respectively. Time course studies showed that hK10 protein started to increase 1 day after steroid hormone stimulation and this increase persisted for 7 days. These data suggest that steroid hormones up-regulate KLK10 gene expression through direct interaction between hormone-receptor complexes and their cognate hormone response elements. To search for hormone response elements, we functionally characterized the KLK10 promoter by placing it upstream of the chloramphenicol acetyltransferase reporter gene. We found that KLK10 promoter activity did not rely on the presence of functional estrogen and androgen receptors. Also, the presence of functional estrogen and androgen receptors did not increase its constitutive activity. We suggest that the hormone response elements that mediate the transcriptional regulation of KLK10 are unlikely to locate in the KLK10 promoter.
CONCLUSIONS: Estrogens, androgens and progestins modulate KLK10 expression through their own receptors but this regulation is not mediated by steroid hormone response elements in the promoter of the KLK10 gene.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14568187     DOI: 10.1016/j.cccn.2003.07.008

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  9 in total

1.  Estrogen receptor-α prevents right ventricular diastolic dysfunction and fibrosis in female rats.

Authors:  Tik-Chee Cheng; Jennifer L Philip; Diana M Tabima; Santosh Kumari; Bakhtiyor Yakubov; Andrea L Frump; Timothy A Hacker; Alessandro Bellofiore; Rongbo Li; Xin Sun; Kara N Goss; Tim Lahm; Naomi C Chesler
Journal:  Am J Physiol Heart Circ Physiol       Date:  2020-10-16       Impact factor: 4.733

2.  Expression analysis and clinical evaluation of kallikrein-related peptidase 10 (KLK10) in colorectal cancer.

Authors:  Maroulio Talieri; Dimitra K Alexopoulou; Andreas Scorilas; Dimitris Kypraios; Niki Arnogiannaki; Marina Devetzi; Matina Patsavela; Dimitris Xynopoulos
Journal:  Tumour Biol       Date:  2011-04-12

3.  The estrogen receptor alpha-derived peptide ERα17p (P(295)-T(311)) exerts pro-apoptotic actions in breast cancer cells in vitro and in vivo, independently from their ERα status.

Authors:  Vassiliki Pelekanou; Marilena Kampa; Dominique Gallo; George Notas; Maria Troullinaki; Hugues Duvillier; Yves Jacquot; Efstathios N Stathopoulos; Elias Castanas; Guy Leclercq
Journal:  Mol Oncol       Date:  2010-11-27       Impact factor: 6.603

4.  Androgens act synergistically to enhance estrogen-induced upregulation of human tissue kallikreins 10, 11, and 14 in breast cancer cells via a membrane bound androgen receptor.

Authors:  Miltiadis Paliouras; Eleftherios P Diamandis
Journal:  Mol Oncol       Date:  2008-01-09       Impact factor: 6.603

5.  Kallikreins 5, 6 and 10 differentially alter pathophysiology and overall survival in an ovarian cancer xenograft model.

Authors:  David Pépin; Zhong-Qi Shao; Geneviève Huppé; Andrea Wakefield; Chee-Wui Chu; Zahra Sharif; Barbara C Vanderhyden
Journal:  PLoS One       Date:  2011-11-15       Impact factor: 3.240

6.  Urinary kallikrein 10 predicts the incurability of gastric cancer.

Authors:  Takaya Shimura; Masahide Ebi; Tomonori Yamada; Tamaki Yamada; Takahito Katano; Yu Nojiri; Hiroyasu Iwasaki; Satoshi Nomura; Noriyuki Hayashi; Yoshinori Mori; Hiromi Kataoka; Marsha A Moses; Takashi Joh
Journal:  Oncotarget       Date:  2017-04-25

7.  Altered mechanisms of genital development identified through integration of DNA methylation and genomic measures in hypospadias.

Authors:  Melissa A Richard; Pagna Sok; Stephen Canon; Wendy N Nembhard; Austin L Brown; Erin C Peckham-Gregory; Minh Ton; Erik A Ehli; Noah A Kallsen; Shanna A Peyton; Gareth E Davies; Ashay Patel; Ismael Zamilpa; Charlotte A Hobbs; Michael E Scheurer; Philip J Lupo
Journal:  Sci Rep       Date:  2020-07-29       Impact factor: 4.379

8.  Structural basis for the Zn2+ inhibition of the zymogen-like kallikrein-related peptidase 10.

Authors:  Mekdes Debela; Viktor Magdolen; Wolfram Bode; Hans Brandstetter; Peter Goettig
Journal:  Biol Chem       Date:  2016-12-01       Impact factor: 3.915

9.  KLK10 exon 3 unmethylated PCR product concentration: a new potential early diagnostic marker in ovarian cancer? - A pilot study.

Authors:  Mustafa A El Sherbini; Amal A Mansour; Maha M Sallam; Emtiaz A Shaban; Zeinab A Shehab ElDin; Amr H El-Shalakany
Journal:  J Ovarian Res       Date:  2018-04-24       Impact factor: 4.234

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.